| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Tempest Therapeutics, Inc. (TPST) has 5 insiders with recent SEC Form 4 filings, including 16 buys and 0 sells. TPST is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 269.6K | $536.5K | - | |
| Dir | 1.2K | $2.4K | - | |
| Dir | 1.2K | $2.4K | - | |
| Dir | 1.2K | $2.4K | - | |
| Dir | 1.2K | $2.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 18, 2016 | Dipp Michelle | Chief Executive Officer | Buy | 20,000 | $7.86 | $157,200.00 | +3.9% | |
| May 17, 2016 | Dipp Michelle | Chief Executive Officer | Buy | 40,000 | $7.63 | $305,000.00 | +4.1% | |
| May 17, 2016 | Aldrich Richard | Director | Buy | 40,000 | $7.63 | $305,000.00 | +4.1% | |
| May 13, 2016 | Dipp Michelle | Chief Executive Officer | Buy | 36,095 | $6.94 | $250,394.70 | +2.7% | |
| May 13, 2016 | Aldrich Richard | Director | Buy | 36,095 | $6.94 | $250,394.70 | +2.7% | |
| May 11, 2016 | Dipp Michelle | Chief Executive Officer | Buy | 20,000 | $7.64 | $152,800.00 | +4.8% | |
| May 11, 2016 | Aldrich Richard | Director | Buy | 20,000 | $7.64 | $152,800.00 | +4.8% | |
| May 10, 2016 | Chapman Paul W.D. | Chief Operating Officer | Buy | 3,100 | $7.37 | $22,847.00 | New | |
| May 10, 2016 | Dipp Michelle | Chief Executive Officer | Buy | 19,900 | $7.72 | $153,628.00 | +5.0% | |
| May 10, 2016 | Aldrich Richard | Director | Buy | 19,900 | $7.72 | $153,628.00 | +5.0% |